CVS Health opening digital innovation lab in Boston

CVS Health will establish a 15,000-square-foot Digital Innovation Lab in Boston, to serve as a hub for the company's growing digital health team.

The company also recently completed the opening of a new Digital Experience Center at the company’s headquarters in Woonsocket, R.I., and is actively recruiting new talent for both locations, according to a release.

“Boston is on the cutting edge of healthcare, and we have a thriving tech environment fueling innovation," said Mayor Martin J. Walsh. "Boston is the ideal location for CVS Health to invest in the Digital Innovation Lab, which will be a source of new ideas that will drive this company into the future."

“As we expand our Digital team and invest in this part of our business, we are truly passionate about using technology to create tools that do not exist anywhere else, so we can empower our customers with a highly personalized pharmacy and retail experience across all channels,” said Brian Tilzer, CVS Health's senior vice president and chief digital officer.

The new lab will have the capacity for 100 employees, with 90 percent of them expected to be new hires. Plans for the new office include the creation of an open concept workspace that encourages idea-sharing and innovation to produce the next level of digital technology that will help enhance the customer experience through convenient, easy-to-use digital tools, according to the release.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.